Inventor · disambiguated record
Shamina M. Rangwala
Also filed as: RANGWALA SHAMINA · RANGWALA SHAMINA M
13 granted patents·9 pending applications·46 citations·filing 2007–2025
92Inventor score
Files withJANSSEN PHARMACEUTICA NV11JANSSEN SCIENCES IRELAND UNLIMITED CO4JANSSEN BIOTECH INC3BRAENDLE EDGAR2NOVARTIS AG1
Top patents by PatentIndex Score
22 records- 0197US11767354B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Sep 26, 2023·3 cites·23 claims
- 0296US10428134B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 1, 2019·7 cites·21 claims
- 0395US11591379B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 28, 2023·3 cites·20 claims
- 0494US10968265B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 6, 2021·4 cites·24 claims
- 0594US10787495B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Sep 29, 2020·3 cites·20 claims
- 0694US10640544B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 5, 2020·4 cites·28 claims
- 0793US11401315B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Aug 2, 2022·2 cites·24 claims
- 0893US10858413B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Dec 8, 2020·3 cites·17 claims
- 0992US2025026803A1Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1089US10336812B2GDF15 fusion proteins and uses thereofJANSSEN BIOTECH INC·Filed 2017·Granted Jul 2, 2019·11 cites·18 claims
- 1187US11208464B2GDF15 fusion proteins and uses thereofJANSSEN BIOTECH INC·Filed 2019·Granted Dec 28, 2021·4 cites·20 claims
- 1286US2023365644A1Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide y receptorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1383US11713345B2Glucagon like peptide 1 (GLP1)-growth differentiation factor 15 (GDF15) fusion proteins and uses thereofJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Aug 1, 2023·2 cites·11 claims
- 1480US12275770B2Glucagon like peptide 1 (GLP1)-growth differentiation factor 15 (GDF15) fusion proteins and uses thereofJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2023·Granted Apr 15, 2025·0 cites·15 claims
- 1578US12134636B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 5, 2024·0 cites·35 claims
- 1669US2025197468A1Glucagon like peptide 1 (glp1)-growth differentiation factor 15 (gdf15) fusion proteins and uses thereofJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2025·Application pending·0 cites
- 1768US2023119382A1Gdf15 fusion proteins and uses thereofJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2021·Application pending·0 cites
- 1849US2014134173A1Composition and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or bothBRAENDLE EDGAR·Filed 2013·Application pending·0 cites
- 1949US2010254980A1Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6)NOVARTIS AG·Filed 2008·Application pending·0 cites
- 2043US2009281191A1Use of organic compoundsRANGWALA SHAMINA M·Filed 2007·Application pending·0 cites
- 2141US2012052070A1Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or bothBRAENDLE EDGAR·Filed 2010·Application pending·0 cites
- 2236US2019234935A1Methods for screening for modulators of gdf15-like biological activityJANSSEN BIOTECH INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shamina M. Rangwala files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →